Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
Tagus 20 mg is indicated for:
-
Management of type 2 diabetes mellitus as monotherapy or with other antidiabetic agents.
-
Enhancing glycemic control when lifestyle changes such as diet and exercise are insufficient.
Pharmacology
Teneligliptin is a DPP-4 inhibitor that increases incretin levels (GLP-1 and GIP). This action enhances insulin secretion and suppresses glucagon release, effectively controlling blood sugar levels.
Dosage and Administration
-
Dosage:
Recommended dose is 20 mg once daily, taken as advised by a physician. Dosage adjustments may depend on patient condition. -
Administration:
Administer orally with or without food at a convenient time.
Interaction
-
Risk of hypoglycemia when combined with sulfonylureas or insulin.
-
May interact with drugs such as digoxin and certain antiretrovirals.
Contraindications
-
Known hypersensitivity to Teneligliptin or its excipients.
-
Patients with severe renal or hepatic impairment.
Side Effects
-
Common: Hypoglycemia, headache, upper respiratory tract infection, and gastrointestinal discomfort.
-
Rare: Pancreatitis, severe allergic reactions, or rash.
Pregnancy & Lactation
-
Pregnancy: Limited data on safety during pregnancy; use only if prescribed by a physician.
-
Lactation: Not recommended as excretion into breast milk is unknown.
Precautions & Warnings
-
Regular blood glucose monitoring is necessary to maintain effective glycemic control.
-
Caution in patients with cardiovascular risks or a history of pancreatitis.
Therapeutic Class
DPP-4 Inhibitors for Antidiabetic Therapy.
Storage Conditions
-
Store in a cool, dry place below 30°C, away from direct sunlight and moisture.
-
Keep out of reach of children.
.jpg)
.jpg)
Change Language